Verici Dx (VRCI) Competitors

ANGLE (LON:AGL) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Does the media favor AGL or VRCI?

In the previous week, ANGLE had 2 more articles in the media than Verici Dx. MarketBeat recorded 2 mentions for ANGLE and 0 mentions for Verici Dx. ANGLE's average media sentiment score of 0.20 beat Verici Dx's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.

Company	Overall Sentiment
ANGLE	Neutral
Verici Dx	Neutral

Do insiders and institutionals have more ownership in AGL or VRCI?

17.5% of ANGLE shares are held by institutional investors. Comparatively, 15.9% of Verici Dx shares are held by institutional investors. 2.7% of ANGLE shares are held by company insiders. Comparatively, 1.0% of Verici Dx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is AGL or VRCI more profitable?

Verici Dx has a net margin of -110.99% compared to ANGLE's net margin of -890.91%. Verici Dx's return on equity of -71.67% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	-890.91%	-76.01%	-29.89%
Verici Dx	-110.99%	-71.67%	-26.14%

Which has higher valuation and earnings, AGL or VRCI?

Verici Dx has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.86M	6.58	-£21.76M	-£0.05	-121.16
Verici Dx	£3.34M	2.30	-£6.56M	-£0.03	-20.32

Do analysts rate AGL or VRCI?

ANGLE presently has a consensus price target of GBX 40, indicating a potential upside of 584.93%. Given ANGLE's stronger consensus rating and higher possible upside, equities research analysts clearly believe ANGLE is more favorable than Verici Dx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Verici Dx	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more risk & volatility, AGL or VRCI?

ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500.

Summary

ANGLE and Verici Dx tied by winning 8 of the 16 factors compared between the two stocks.